Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Fatigue, Feeling hot, Headache, Hypersensitivity
Clinical narrative: Hypersensitivity reaction; Slept extra; Felt achy; Feeling hot; Like I had a flu; Redness, Generalised; Headache; tired; pretty full red body rash; This spontaneous case was reported by an other health care professional and describes the occurrence of HYPERSENSITIVITY (Hypersensitivity reaction), SOMNOLENCE (Slept extra), MYALGIA (Felt achy), FEELING HOT (Feeling hot) and INFLUENZA LIKE ILLNESS (Like I had a flu) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Hives, Asthma since an unknown date, Arthritis since an unknown date and Pain since an unknown date. Concomitant products included CELECOXIB (CELEBREX) for Arthritis, MONTELUKAST for Asthma, METHOCARBAMOL (ROBAXIN) for Muscle relaxant, MOMETASONE FUROATE (FLONASE [MOMETASONE FUROATE]) for Nasal discomfort, HYDROCODONE and MORPHINE for Pain.    On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Mar-2021, the patient experienced RASH (pretty full red body rash). On an unknown date, the patient experienced HYPERSENSITIVITY (Hypersensitivity reaction), SOMNOLENCE (Slept extra), MYALGIA (Felt achy), FEELING HOT (Feeling hot), INFLUENZA LIKE ILLNESS (Like I had a flu), ERYTHEMA (Redness, Generalised), HEADACHE (Headache) and FATIGUE (tired). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at a dose of UNK, bid; CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) for Adverse event, at a dose of UNK, bid and NAPROXEN SODIUM (ALEVE) for Adverse event, at an unspecified dose and frequency. At the time of the report, HYPERSENSITIVITY (Hypersensitivity reaction), SOMNOLENCE (Slept extra), MYALGIA (Felt achy), FEELING HOT (Feeling hot), INFLUENZA LIKE ILLNESS (Like I had a flu), ERYTHEMA (Redness, Generalised), RASH (pretty full red body rash) and FATIGUE (tired) outcome was unknown and HEADACHE (Headache) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Most recent FOLLOW-UP information incorporated above includes: On 21-Jun-2021: Significant follow up appended This case was initially received via an unknown source (no reference has been entered for a health authority or license partner) on 24-Mar-2021. The most recent information was received on 21-Jun-2021 and was forwarded to Moderna on 21-Jun-2021.    This spontaneous case was reported by an other health care professional and describes the occurrence of HYPERSENSITIVITY (Hypersensitivity reaction), SOMNOLENCE (Slept extra), MYALGIA (Felt achy), FEELING HOT (Feeling hot) and INFLUENZA LIKE ILLNESS (Like I had a flu) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Hives, Asthma since an unknown date, Arthritis since an unknown date and Pain since an unknown date. Concomitant products included CELECOXIB (CELEBREX) for Arthritis, MONTELUKAST for Asthma, METHOCARBAMOL (ROBAXIN) for Muscle relaxant, MOMETASONE FUROATE (FLONASE [MOMETASONE FUROATE]) for Nasal discomfort, HYDROCODONE and MORPHINE for Pain.    On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Mar-2021, the patient experienced RASH (pretty full red body rash). On an unknown date, the patient experienced HYPERSENSITIVITY (Hypersensitivity reaction), SOMNOLENCE (Slept extra), MYALGIA (Felt achy), FEELING HOT (Feeling hot), INFLUENZA LIKE ILLNESS (Like I had a flu), ERYTHEMA (Redness, Generalised), HEADACHE (Headache) and FATIGUE (tired). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at a dose of UNK, bid; CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) for Adverse event, at a dose of UNK, bid and NAPROXEN SODIUM (ALEVE) for Adverse event, at an unspecified dose and frequency. At the time of the report, HYPERSENSITIVITY (Hypersensitivity reaction), SOMNOLENCE (Slept extra), MYALGIA (Felt achy), FEELING HOT (Feeling hot), INFLUENZA LIKE ILLNESS (Like I had a flu), ERYTHEMA (Redness, Generalised), RASH (pretty full red body rash) and FATIGUE (tired) outcome was unknown and HEADACHE (Headache) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Most recent FOLLOW-UP information incorporated above includes: On 21-Jun-2021: Significant follow up appended